Fenwick & West represented Flip AI in the transaction. Flip AI announced its $6.5 million Seed financing. The round was led by Factory with participation from Morgan...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented OrsoBio in the transaction. OrsoBio, Inc. announced its $60 million Series A financing, bringing the total capital raised by the Company to $97 million....
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Sawyer in the transaction. DaySmart Software announced its acquisition of Sawyer, a provider of business management software for the children’s activities end market....
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Samara on the transaction. Samara announced its $41 million Series A financing. The round was led by Thrive Capital with participation from 8VC,...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Atara Biotherapeutics, Inc. in the transaction. Atara Biotherapeutics, Inc. (Nasdaq: ATRA) announced it has entered into an expanded partnership with Pierre Fabre...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Traba in the transaction. Traba announced its $22 million financing. The round was led by Founders Fund, with participation from Khosla Ventures. Traba...
You must be a Standard 1 Year member to access this content.
Fenwick & West is representing Databricks Inc. in the transaction. Databricks Inc. announced its acquisition of Arcion, a Databricks Ventures portfolio company. The transaction will allow Databricks to...
You must be a Standard 1 Year member to access this content.
Fenwick & West, Goodwin Procter and Maiwald represented Royalty Pharma in the transaction, Wilmer Cutler Pickering Hale and Dorr represented PTC Therapeutics. Royalty Pharma plc (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Mphasis on the transaction. Mphasis (BSE: 526299, NSE: MPHASIS) announced its acquisition of Silverline for $132.5 million. Silverline will give Mphasis expertise in...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Mojo Vision on the transaction. Mojo Vision announced a final close of its $43.5 million new Series A investment round to drive...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Opsera in the transaction. Opsera announced its $12 million Series A financing. The round was led by Taiwania Capital, with participation from Felicis...
You must be a Standard 1 Year member to access this content.
